Advertisement
Screener

LA JOLLA PHARMACEUTICAL CO Form 425: Prospectus or communication for a business combination

LA JOLLA PHARMACEUTICAL CO Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-07-11: Form 425; Description 425; Document d378167d425.htm.
  • 2010-03-01: Form 425; Description LIVE FILING; Document htm_36548.htm.
  • 2010-02-24: Form 425; Description LIVE FILING; Document htm_36447.htm.
  • 2010-02-19: Form 425; Description LIVE FILING; Document htm_36379.htm.
FiledFormPeriod of reportDescriptionDocument
2022-07-11425425d378167d425.htm
2010-03-01425LIVE FILINGhtm_36548.htm
2010-02-24425LIVE FILINGhtm_36447.htm
2010-02-19425LIVE FILINGhtm_36379.htm
2010-02-16425LIVE FILINGhtm_36300.htm
2009-12-22425LIVE FILINGhtm_35625.htm
2009-12-07425LIVE FILINGhtm_35409.htm